Barry Steele Buys 2,064 Shares of InfuSystem (NYSE:INFU) Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry Steele bought 2,064 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were bought at an average price of $9.16 per share, with a total value of $18,906.24. Following the completion of the purchase, the chief financial officer owned 88,000 shares in the company, valued at approximately $806,080. The trade was a 2.40% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

InfuSystem Stock Performance

Shares of INFU opened at $9.18 on Wednesday. The firm has a market capitalization of $186.68 million, a P/E ratio of 153.03 and a beta of 1.67. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. InfuSystem Holdings, Inc. has a one year low of $4.61 and a one year high of $11.04. The business has a fifty day moving average of $8.41 and a 200 day moving average of $9.32.

Analysts Set New Price Targets

Separately, Roth Mkm reissued a “buy” rating and issued a $15.00 price objective (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $15.00.

Institutional Trading of InfuSystem

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Hillsdale Investment Management Inc. bought a new position in shares of InfuSystem during the 3rd quarter valued at approximately $4,665,000. Integrated Quantitative Investments LLC bought a new position in shares of InfuSystem in the second quarter worth approximately $243,000. Truffle Hound Capital LLC purchased a new stake in shares of InfuSystem in the second quarter worth $1,123,000. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of InfuSystem by 38.9% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 69,772 shares of the company’s stock valued at $435,000 after purchasing an additional 19,554 shares during the period. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of InfuSystem during the 2nd quarter valued at $294,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.